Petix & Botte Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $972K | Sell |
5,234
-3,384
| -39% | -$628K | 0.24% | 57 |
|
|
2025
Q1 | $1.81M | Hold |
8,618
| – | – | 0.48% | 40 |
|
|
2024
Q4 | $1.53M | Hold |
8,618
| – | – | 0.4% | 45 |
|
|
2024
Q3 | $1.7M | Hold |
8,618
| – | – | 0.45% | 36 |
|
|
2024
Q2 | $1.48M | Buy |
8,618
+4,309
| +100% | +$739K | 0.42% | 37 |
|
|
2024
Q1 | $785K | Sell |
4,309
-4,327
| -50% | -$788K | 0.19% | 75 |
|
|
2023
Q4 | $1.34M | Buy |
8,636
+18
| +0.2% | +$2.79K | 0.39% | 39 |
|
|
2023
Q3 | $1.28M | Hold |
8,618
| – | – | 0.41% | 39 |
|
|
2023
Q2 | $1.16M | Buy |
8,618
+4,309
| +100% | +$581K | 0.36% | 42 |
|
|
2023
Q1 | $687K | Buy |
+4,309
| New | +$687K | 0.46% | 41 |
|
|
2022
Q3 | $578K | Buy |
4,309
+414
| +11% | +$55.5K | 0.44% | 39 |
|
|
2022
Q2 | $597K | Sell |
3,895
-3,895
| -50% | -$597K | 0.44% | 40 |
|
|
2022
Q1 | $1.26M | Buy |
7,790
+3,895
| +100% | +$632K | 0.39% | 39 |
|
|
2021
Q4 | $527K | Sell |
3,895
-3,853
| -50% | -$521K | 0.34% | 47 |
|
|
2021
Q3 | $836K | Buy |
7,748
+3,874
| +100% | +$418K | 0.28% | 52 |
|
|
2021
Q2 | $436K | Hold |
3,874
| – | – | 0.3% | 56 |
|
|
2021
Q1 | $419K | Hold |
3,874
| – | – | 0.31% | 57 |
|
|
2020
Q4 | $415K | Hold |
3,874
| – | – | 0.31% | 56 |
|
|
2020
Q3 | $339K | Sell |
3,874
-3,874
| -50% | -$339K | 0.27% | 60 |
|
|
2020
Q2 | $381K | Buy |
7,748
+3,874
| +100% | +$191K | 0.31% | 54 |
|
|
2020
Q1 | $295K | Buy |
3,874
+200
| +5% | +$15.2K | 0.29% | 57 |
|
|
2019
Q4 | $325K | Buy |
+3,674
| New | +$325K | 0.26% | 63 |
|